PROGNOSTIC AND THERPEUTIC POTENTIAL OF IMBALANCE BETWEEN PD-1+CD8 AND ICOS+ REGULATORY T CELLS IN ADVANCED HBV- HCC

被引：0
|
作者：
Yan Fengna
机构：
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
245
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [21] PD-1 Expression on Circulating CD8+ T-Cells as a Prognostic Marker for Patients With Gastric Cancer
    Saito, Hiroaki
    Shimizu, Shota
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Miyatani, Kozo
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2019, 39 (01) : 443 - 448
  • [22] Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II
    Dieckman, Tessa
    Schreurs, Mette
    Lindelauf, Ciska
    Mahfouz, Ahmed
    Meijer, Caroline R.
    Pigeaud, Louise
    van Unen, Vincent
    Bouma, Gerd
    Koning, Frits
    GASTRO HEP ADVANCES, 2025, 4 (01):
  • [23] Clinical significance of CD101+PD-1+CD8 T cells in malignant ascites among patients with advanced ovarian cancer
    Lee, Dahye
    Park, Junsik
    Lee, Yong Jae
    Kim, Sang Wun
    Kim, Sunghoon
    Lee, Jung-Yun
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S224 - S224
  • [24] Responsiveness of HBV-specific CD8+T cells to PD1 pathway blockade is linked to TCF1 expression
    Schuch, A.
    Wieland, D.
    Hofmann, M.
    Thimme, R.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S30 - S30
  • [25] Multifunctionality of CD8+ T cells and PD-L1 expression as a biomarker of anti-PD-1 antibody efficacy in advanced melanoma
    Manabe, Keiko
    Yamasaki, Osamu
    Nakagawa, Yuki
    Miyake, Tomoko
    Udono, Heiichiro
    Morizane, Shin
    JOURNAL OF DERMATOLOGY, 2021, 48 (08): : 1186 - 1192
  • [26] Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC
    Zhang, Yonghui
    Zhang, Hailin
    Wei, Mei
    Mou, Tao
    Shi, Tao
    Ma, Yanyu
    Cai, Xinyu
    Li, Yunzheng
    Dong, Jie
    Wei, Jiwu
    MOLECULAR THERAPY, 2019, 27 (11) : 1906 - 1918
  • [27] Identification of clinically relevant subsets CD39+PD-1+CD8+T cells and CD39+regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF
    Zhang, Qi-Wei
    Zhu, Meng-Xuan
    Liu, Wen-Feng
    Rui, Wei -Wei
    Chen, Yong
    Ding, Xiao-Yi
    Jiang, Yong-Sheng
    Wu, Zhi-Yuan
    Liu, Bin-Bin
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [28] Characterization of reguratory functions of a novel alloantigen specific CD8+PD-1+ regulatory T cell induced by ICOS-B7h blockade in vivo.
    Yamaura, Kazuhiro
    Izawa, Atsushi
    Albin, Monica J.
    Sayegh, Moharned H.
    Najafian, Nader
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 229 - 229
  • [29] PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma
    Homicsko, Krisztian
    Zygoura, Panagiota
    Norkin, Maxim
    Tissot, Stephanie
    Shakarishvili, Nicholas
    Popat, Sanjay
    Curioni-Fontecedro, Alessandra
    O'Brien, Mary
    Pope, Anthony
    Shah, Riyaz
    Fisher, Patricia
    Spicer, James
    Roy, Amy
    Gilligan, David
    Rusakiewicz, Sylvie
    Fortis, Ekaterina
    Marti, Nesa
    Kammler, Roswitha
    Finn, Stephen P.
    Coukos, Georges
    Dafni, Urania
    Peters, Solange
    Stahel, Rolf A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [30] Single-cell analysis reveals HBV-specific PD-1+CD8+ TRM cells in tumor borders are associated with HBV-related hepatic damage and fibrosis in HCC patients
    Liu, Lulu
    Liu, Junwei
    Li, Pan
    Luo, Jijun
    Qin, Rui
    Peng, Qiao
    Li, Bin
    Wei, Xuyong
    Wang, Tian
    Shi, Hongyu
    Wang, Ming-Da
    Li, Chao
    Fang, Weijia
    Chen, Wei
    Xu, Xiao
    Yang, Tian
    Yin, Weiwei
    Zeng, Xun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
12345